Status:
COMPLETED
Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Fibrosis
Eligibility:
All Genders
20+ years
Brief Summary
This is a non-interventional, multi-center study to collect data from patients with idiopathic pulmonary fibrosis (IPF) in clinical practice in Taiwan. The study will be carried out at 10 medical cent...
Eligibility Criteria
Inclusion
- Patients can be included if ALL the following criteria are met:
- Newly diagnosed with IPF within 6 months based upon recent ATS/ERS/JRS/ALAT IPF guideline (Ref 1, Raghu G, et al. 2011).
- Exclusion of other known causes of ILD (e.g. domestic and occupational environmental exposures, connective tissue disease, and drug toxicity).
- Assessment of IPF based on HRCT or HRCT and surgical lung biopsy, if available. 2.Patient ≥ 20 years of age 3.Written informed consent prior to participation 4.Patients with further follow-up possible with participating physician during planned study period 5.Ability to read and write in the local language
Exclusion
- Patients should not be included if ANY of the following criteria is met:
- Lung transplantation expected within next 6 months.
- Inclusion in ongoing clinical trials.
Key Trial Info
Start Date :
August 17 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 18 2020
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03242759
Start Date
August 17 2017
End Date
February 18 2020
Last Update
April 13 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang-Hua Christian Hospital
Changhua, Taiwan, 500
2
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807
3
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 83301
4
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220